Anebulo Pharmaceuticals, Inc. ANEB 深 滬
等待開盤 01-28 09:30:00 美东时间
0.9101
-0.170
-15.73%
華盛通- 最 高0.99
- 今 開0.99
- 成交量 9.04万股
- 最 低 0.8838
- 昨 收 1.08
- 總市值 3739.12万
- 52周最高 3.42
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.8838
- 委 比 14.02%
- 總股本 4108.47万
- 歷史最高 9.33
- 量 比 1.49
- 振 幅 9.83%
- 歷史最低 0.8001
- 每 手 1
- 風險率 0.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Anebulo Pharmaceuticals Buys Back 300,000 Shares for $1.05 Million
Anebulo Pharmaceuticals Buys Back 300,000 Shares for $1.05 Million Anebulo Pharmaceuticals Inc. has announced the preliminary results of its voluntary self-tender offer, with the company expecting to purchase 300,000 shares of its common stock at a purchase price of $3.50 per share, for an aggregate
01-27 22:49
Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results
Anebulo Pharmaceuticals ( ($ANEB) ) has shared an update. On January 27, 2026, ...
01-27 22:48
How Do Investors Really Feel About Anebulo Pharmaceuticals Inc?
Anebulo Pharmaceuticals Inc's (NYSE:ANEB) short interest as a percent of float ...
01-22 23:00
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers SciSparc (NASDAQ:SPRC) shares rose 6.3% to $1.46 during Monday's after...
2025-12-30 05:05
How Is The Market Feeling About Anebulo Pharmaceuticals Inc?
Anebulo Pharmaceuticals Inc's (NYSE:ANEB) short interest as a percent of float ...
2025-12-27 01:00
Anebulo To Commence $3.50/Shr Cash Tender Offer For Up To 300K Shares As Part Of Plan To Go Private In Lieu Of Reverse Stock Split At Ratio Of Not Less Than 1-For-2,500 And Not Greater Than 1-For-7,500
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or "Anebulo"), today announced
2025-12-22 22:05
Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 37.5 percent increase over losses of $(0.08) per share
2025-11-14 05:33
Anebulo Pharmaceuticals Advances Cannabis Toxicity Treatment
Anebulo Pharmaceuticals, Inc. ( ($ANEB) ) has released its Q4 earnings. Here is...
2025-10-01 14:51
Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It
The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desperate for deal approval.
2025-09-19 23:58
Anebulo Pharmaceuticals Weighs Going Private As Board Reviews Strategic Alternatives
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the "Company" or "Anebulo"), today
2025-09-12 19:32
